Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 74 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8846643

    Phosphonates with reduced toxicity for treatment of viral infections

    The Regents of the University of California · Granted Sep 30, 2014 · Expires Sep 25, 2034

    granted
  2. US 8840905

    Use of neurotoxin therapy for treatment of urologic and related disorders

    The Regents of the University of Colorado · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  3. US 8841273

    Methods and compositions for anti-EGFR treatment

    The Board of Regents of the University of Texas System · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted
  4. US 8835491

    Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  5. US 8834854

    Oral treatment compositions and related methods of manufacture

    Ranir, LLC · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  6. US 8829030

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  7. US 8828971

    Galactose-pronged carbohydrate compounds for the treatment of diabetic nephropathy and associated disorders

    GALECTIN THERAPEUTICS, INC. · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  8. US 8828380

    Method for the treatment of pulmonary disease and method of producing proteins of use therein

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  9. US 8828356

    Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  10. US 8828980

    Controlled release corticosteroid compositions and methods for the treatment of otic disorders

    The Regents of the University of California · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  11. US 8821880

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  12. US 8822540

    Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  13. US 8822196

    Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted
  14. US 8815240

    Methods and agents for the diagnosis and treatment of hepatocellular carcinoma

    China Synthetic Rubber Corporation · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  15. US 8815951

    Inhibitors of epoxide hydrolases for the treatment of inflammation

    The Regents of the University of California · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  16. US 8809291

    Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma

    The Regents of the University of California · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  17. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  18. US 8802844

    Isothiazolopyridinones useful for the treatment of (inter alia) cystic fibrosis

    Vertex Pharmaceuticals Incorporated · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  19. US 8802689

    Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases

    The Regents of the University of California · Granted Aug 12, 2014 · Expires Aug 7, 2034

    granted
  20. US 8796302

    Methods related to the treatment of neurodegenerative and inflammatory conditions

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  21. US 8795677

    Treatment methods using an F1-V plague vaccine

    The United States of America as represented by the Secretary of the Army · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  22. US 8795964

    GRM3 mutations and use thereof for the diagnosis and treatment of melanoma

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  23. US 8791092

    Molecular tweezers for the treatment of amyloid-related diseases

    The Regents of the University of California · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted
  24. US 8790878

    Diagnosis and treatment of breast cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 29, 2014 · Expires Jul 24, 2034

    granted